🔗 Permalink

Inventor profile of:

John K. Jackson

City:

Vancouver

Country:

Canada

Published Applications:

Last publication date:

2019-07-04

Top Assignees for applications by John K. Jackson

The entities that hold a legal rights for patent applications filed by inventor Jackson John K.:

ANGIOTECH PHARMACEUTICALS, INC. 11 VANCOUVER, Canada
The University of British Columbia 9 Vancouver, Canada
Centre for Drug Research and Development 4 Vancouver, Canada
The University of British Columbia 2 Vancouver, BC Canada
ANGIOTECH INTERNATIONAL AG 1 Zug, Switzerland
UNIVERSITY OF BRITISH COLUMBIA 1 Vancouver, Canada
Angiotech Pharmaceuticals, Inc. 1 , Canada
Centre for Drug Research and Development 1 Vancouver, BC Canada

Recent patent applications by Jackson John K.

John K. Jackson from Vancouver, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-07-04

US20190201528A1

Human necessities

Derivatized hyperbranched polyglycerols

#2 | 2017-11-09

US20170319696A1

Human necessities

Derivatized hyperbranched polyglycerols

#3 | 2016-04-28

US20160114040A1

Human necessities

Derivatized hyperbranched polyglycerols

#4 | 2013-05-16

US20130122112A1

Human necessities

Derivatized hyperbranched polyglycerols

#5 | 2010-11-18

US20100292314A1

Human necessities

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#6 | 2010-09-23

US20100240742A1

Human necessities

Anti-angiogenic nanoparticle compositions

#7 | 2010-07-08

US20100174356A1

Human necessities

STENT GRAFTS WITH BIOACTIVE COATINGS

#8 | 2009-04-23

US20090105351A1

Human necessities

Micellar drug delivery systems for hydrophobic drugs

#9 | 2009-03-19

US20090074830A1

Human necessities

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#10 | 2009-02-05

US20090036517A1

Human necessities

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#11 | 2008-07-10

US20080166387A1

Human necessities

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#12 | 2008-01-24

US20080020063A1

Human necessities

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#13 | 2007-12-27

US20070298123A1

Human necessities

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

#14 | 2007-10-11

US20070238697A1

Human necessities

Pharmaceutical compositions and methods relating to fucans

#15 | 2007-01-04

US20070003630A1

Human necessities

Anti-angiogenic compositions and methods of use

#16 | 2007-01-04

US20070003629A1

Human necessities

Anti-angiogenic compositions and methods of use

#17 | 2006-10-26

US20060240113A1

Human necessities

Anti-angiogenic compositions and methods of use

#18 | 2006-08-24

US20060189785A1

Human necessities

Micellar drug delivery systems for hydrophobic drugs

#19 | 2006-06-15

US20060127445A1

Human necessities

Anti-angiogenic compositions and methods of use

#20 | 2006-06-08

US20060121117A1

Human necessities

Anti-angiogenic compositions and methods of use

#21 | 2006-02-23

US20060040894A1

Human necessities

Compositions and methods using hyaluronic acid

#22 | 2005-09-22

US20050208137A1

Human necessities

Anti-angiogenic compositions and methods of use

#23 | 2005-08-04

US20050171594A1

Human necessities

Stent grafts with bioactive coatings

#24 | 2005-06-09

US20050123605A1

Human necessities

Anti-angiogenic compositions and methods of use

#25 | 2005-06-02

US20050119216A1

Human necessities

Pharmaceutical compositions and methods relating to fucans

#26 | 2005-04-07

US20050074496A1

Human necessities

Pharmaceutical compositions and methods relating to fucans

#27 | 2005-01-27

US20050021126A1

Human necessities

Stent grafts with bioactive coatings

InventorID:

246918 ⎘